Integra LifeSciences Holdings Corporation (FRA:IL3)

Market Cap	1.05B +10.6%
Revenue (ttm)	1.43B +1.2%
Net Income	-430.01M
EPS	-5.60
Shares Out	n/a
PE Ratio	n/a
Forward PE	6.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	13.30
Previous Close	13.30
Day's Range	13.30 - 13.30
52-Week Range	7.60 - 14.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 5, 2026

About FRA:IL3

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1989
• Employees: 4,427
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IL3

Financial Performance

In 2025, FRA:IL3's revenue was $1.64 billion, an increase of 1.53% compared to the previous year's $1.61 billion. Losses were -$516.47 million, 7337.7% more than in 2024.

Financial numbers in USD